SECURITIES AND EXCHANGE COMMISSION
                                WASHINGTON, D. C.


                                    FORM 10-Q


                   QUARTERLY REPORT UNDER SECTION 13 OR 15 (D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


FOR QUARTER ENDED:  DECEMBERMARCH 31, 20002001  COMMISSION FILE NO. 0-4076
                   --------------------------------                      ------



                              EXOTECH INCORPORATED
               ----------------------------------------------------------------------
               (Exact name of Registrant as Specified in Charter)





State or Jurisdiction of
Incorporation or Organization:STATE OR JURISDICTION OF
INCORPORATION OR ORGANIZATION:             DELAWARE

IRS Identification No:IDENTIFICATION NO:                     54-0700888

Address of Principal Office:ADDRESS OF PRINCIPAL OFFICE:               8502 Dakota Drive
                                               Gaithersburg,DAKOTA DRIVE
                                           GAITHERSBURG, MD. 20877

Registrant's Telephone Number:REGISTRANT'S TELEPHONE NUMBER:             (301) 948-3060




Indicate by checkmark whether the RegistrantINDICATE BY CHECKMARK WHETHER THE REGISTRANT (1) has filed all reports required
to be filed by SectionHAS FILED ALL REPORTS REQUIRED
TO BE FILED BY SECTION 13 orOR 15(d) of the Securities Exchange Act ofOF THE SECURITIES EXCHANGE ACT OF 1934 during
the precedingDURING
THE PRECEDING 12 months (or for such shorter period that the Registrant was
required to file such reports)MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE REGISTRANT WAS
REQUIRED TO FILE SUCH REPORTS), andAND (2) has been subject to such filing
requirement for the pastHAS BEEN SUBJECT TO SUCH FILING
REQUIREMENT FOR THE PAST 90 days.

                           YesDAYS.

                   YES      [X]              NoNO       [ ]

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the close of the period covered by this Report.INDICATE THE NUMBER OF SHARES OUTSTANDING OF EACH OF THE ISSUER'S CLASSES OF
COMMON STOCK, AS OF THE CLOSE OF THE PERIOD COVERED BY THIS REPORT.

CLASS:                            COMMON STOCK, PAR VALUE $0.10
                                  -----------------------------
OUTSTANDING AT
  DECEMBERMARCH 31, 2000:2001            942,387
                            -------





                              EXOTECH INCORPORATED


                                      INDEX

PAGE PART I FINANCIAL INFORMATIONINFORMATION.......................................................PAGE NO. CONSOLIDATED CONDENSED BALANCE SHEET DECEMBERMarch 31, 20002001 AND JUNE 30, 2000...............................22000.............................................. 2 CONSOLIDATED CONDENSED STATEMENT OF OPERATIONS - SIXNINE MONTHS ENDED DECEMBERMARCH 31, 20002001 AND 1999........................................32000....................................................... 3 STATEMENT OF CASH FLOWS FOR SIXNINE MONTHS ENDED DECEMBERMARCH 31, 20002001 AND 1999...........................42000.......................................... 4 NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS..............................................5STATEMENTS.......................................................... 5 MANAGEMENT'S DISCUSSION AND ANALYSIS OF CONSOLIDATED CONDENSED STATEMENT OF OPERATIONS.....................................................6OPERATIONS................................................................. 6 PART II OTHER INFORMATION OTHER FINANCIAL INFORMATION.......................................8 SIGNATURES........................................................9INFORMATION................................................... 8 SIGNATURES.................................................................... 9
EXOTECH INCORPORATED CONSOLIDATED BALANCE SHEET ASSETS
ASSETS DECEMBERMARCH 31, JUNE 30, 2001 2000 2000 --------------- --------------------------- ------------ (Unaudited) CURRENT ASSETS Accts. Receivable, Net $ 13,5581,180 $ 12,633 Inventories Work in Process 271,206267,708 267,217 Raw Materials 32,625 32,625 Finished Goods 14,000 14,000 Cash and Other Current Assets 1,5622,673 3,861 -------- ------------------- ----------- Total Current Assets $332,951 $330,336$ 318,186 $ 330,336 PROPERTY, PLANT AND EQUIPMENT, NET 1,9811,839 2,265 OTHER NON CURRENT ASSETS 4.080 4,080 4,080 -------- ------------------- ----------- TOTAL ASSETS $339,012$324,105 $336,681 ======== =================== =========== LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES Accts. Payable & Other Accrued Expenses $ 18,7927,352 $ 13,053 Other Current Liabilities 379,874385,800 396,267 Notes Payable 400,918399,348 403,223 ---------- --------------------- ----------- Total Current Liabilities $799,584 $812,543$ 792,500 $ 812,543 SHAREHOLDERS EQUITY Common Stock, Par Value $.10 per share; 1,500,000 shares authorized; 970,135 issued; 942,387 outstanding 97,014 97,014 Paid-in-Surplus 1,169,645 1,169,645 Deficit (1,614,811)(1,622,634) (1,630,101) Treasury Stock (27,748 shares) (112,420) (112,420) ---------- ---------------------- ------------ Total Shareholders' Equity (460,572)(468,395) (475,862) TOTAL LIABILITIES & SHAREHOLDERS' EQUITY $ 339,012324,105 $ 336,681 ========== ===================== ===========
See accompanying Notes to Consolidated Condensed Financial Statements. 2 EXOTECH INCORPORATED CONSOLIDATED CONDENSED STATEMENT OF OPERATIONS
2001 2000 1999 ----------------------- ------------------------------------------------------- ------------------------------ 3 Mos. 69 Mos. 3 Mos. 69 Mos. ----------- ENDED ----------- ----------- ENDED ----------- 12/------------ 3/31 12/3/31 12/3/31 12/3/31 ----- ----- ----- ----------- ------ ------ ------ REVENUE Contract Sales 42,776 108,893 156,791 363,872$10,051 $118,944 $42,073 $405,945 EXPENSES Direct Labor 270 2113 95 397974 3,087 1,673 2,070 Overhead 2,241 9,373 2,844 5,6733,719 13,092 5,233 10,906 Materials 1,398-- 2,000 (220) 10,700852 11,552 Other Direct Costs 4,043 4,924-- 3,351 100 100 Travel -- 1,573 -- -- General & Administrative 1,822 3,841 662 2,5342,640 6,481 1,750 4,284 Inventory Costs 43,272 73,491 135,599 290,813 ------ ------- ------- -------17,019 90,510 28,170 318,983 --------- -------- -------- --------- Cost of Contract Services 53,046 95,742 138,980 310,11724,352 120,094 37,778 347,895 Operating Income (Loss) (10,270) 13,151 17,811 53,755 Other(14,301) (1,150) 4,295 58,050 Miscellaneous Income (Expense) 17,867 17,86914,191 32,060 585 585 Research and Development -- -- -- -- Interest & Other (7,860) (15,730) (7,784) (15,568)(7,714) (23,444) (7,576) (23,144) ------- -------- ------- ------- --------------- NET INCOME BEFORE TAXES (263) 15,290 10,027 38,187(7,824) 7,466 (2,696) 35,491 State Income Tax Provision -- -- -- -- ------- -------- ------- ------- --------------- NET INCOME (LOSS) (263) 15,290 10,027 38,187(7,824) 7,466 (2,696) 35,491 Weighted Average Number of Common Shares Outstanding 942,387 942,387 942,387 942,387 EARNINGS (LOSS) PER COMMON SHARE (.00) .016 .01 .04(0.01) 0.01 (0.00) 0.04 DIVIDENDS PER COMMON SHARE None None None None
See accompanying Notes to Consolidated Condensed Financial Statements. These statements have been prepared from the books of account without audit. 3 EXOTECH INCORPORATED AND SUBSIDIARY STATEMENT OF CASH FLOWS FOR SIXNINE MONTHS ENDED DECEMBERMARCH 31,
2001 2000 1999 ---- ---------- ------ CASH FLOWS FROM OPERATING TRANSACTIONS Net Income (Loss) 15,290 38,1877,466 35,491 Add: Non cash Income Determinants Depreciation and Amortization 284 769427 988 Add (Deduct): Changes in Current Assets & Liabilities (Increase) Decrease in Accounts Receivable (925) 30,11811,453 64,649 (Increase) Decrease in Prepaid Expense 1296Expenses 1,737 600 (Increase) Decrease in Inventory (3,989) 73,672(491) 42,669 Increase (Decrease) in Accts. Payable 5,739 (1,859)(5,701) (11,275) Increase (Decrease) in Payroll/Emp.Employee Benefits (31,961) (38,499)(34,250) (50,504) Increase (Decrease) in Accrued Interest 15,568 15,56923,183 23,268 Increase (Decrease) in Progress Payments (78,000) ------- -------600 (80,900) -------- --------- Cash PROVIDED BY or (USED FOR) Operating Transactions 1,302 40,5574,424 24,986 CASH FLOWS FROM FINANCING TRANSACTIONS: Proceeds from Notes -- -- Payments on Notes (2305) (13,000) ------- -------(3,875) (13,849) -------- --------- Cash PROVIDED BY or (USED FOR) Financing Transactions (2305) (13,000)(3,875) (13,849) CASH FLOWS FROM INVESTING TRANSACTIONS: Purchase of Equipment -- (1149)(1,149) Deposits -- (201) ------- -------(114) -------- --------- Cash PROVIDED BY or (USED FOR) Investing Transactions -- (1,350)0 (1,263) INCREASE (DECREASE) IN CASH (1,003) 26,207549 9,874 CASH BALANCE - BEGINNING 1,921 8,868 ------- --------------- --------- CASH BALANCE - ENDING 918 35,075 ======= =======$ 2,470 $ 18,742 ======== =========
4 EXOTECH INCORPORATED NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS NOTE 1. In the opinion of Management, the accompanying unaudited consolidated condensed financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly the financial position as of DecemberMarch 31, 20002001 and June 30, 2000 and the results of operations and changes in financial position for the sixnine months ended DecemberMarch 31, 20002001 and 19992000 of Exotech Incorporated and its inactive wholly-owned consolidated subsidiary, Exotech Research & Analysis, Inc. There are no significant intercompany transactions. NOTE 2. Per share computations have been based on the weighted average shares outstanding of 942,387 for the sixnine months ended DecemberMarch 31, 20002001 and 1999.2000. NOTE 3. Notes Payable at DecemberMarch 31, 20002001 consist of four demand notes of $100,000, $8,000 and $47,000, payable with interest at 8.5% per annum to three of the Company's former directors. In addition, one demand note of $245,918$244,348 is payable with interest at 8.5% per annum to one officer/employee. Periodically,NOTE 4. Inventory cost shown in the Company has obtained producer loans from Spiral Biotech, Inc.cost of sales, represents the cost of production of goods sold that are secured by inventory instruments. At December 31, 2000, there was no outstanding Producer Loan.were incurred in the prior fiscal year. 5 MANAGEMENT'S DISCUSSION AND ANALYSIS OF THE CONSOLIDATED CONDENSED STATEMENT OF OPERATIONS The following is Management's discussion and analysis of certain significant factors which have affected the Company's earnings during the periods included in the accompanying consolidated condensed statement of operations. A summary of the period to period changes in the principal items included in the consolidated statement of operations is shown below:
---------------------------------------------------------------------- COMPARISON OF ----------------------------------------------------------------------------- THREE MONTHS THREE MONTHS SIXNINE MONTHS ---------------- ---------------- --------------------- Dec 31 Sept 30 Dec----------------------- ----------------------- ------------------------ Mar 31 Dec 31 DecMar 31 DecMar 31 Mar 31 Mar 31 2001 2000 2001 2000 2001 2000 1999 2000 1999 Net Sales 10,051 42,776 66,117 42,776 156,791 108,893 363,87210,051 42,073 118,944 405,945 Direct CostCosts & Overhead 4,693 7,952 10,458 7,952 2,719 18,410 16,7704,693 7,858 23,103 24,628 G&A Expense 2,640 1,822 2,019 1,822 662 3,841 2,5342,640 1,750 6,481 4,284 Inventory Cost 17,019 43,272 30,219 43,272 135,599 73,491 290,813 ------ ------ ------ ------- ------- -------17,019 28,170 90,510 318,983 --------- -------- --------- -------- -------- --------- Cost of Sales 24,352 53,046 42,696 53,046 138,980 95,742 310,11724,352 37,778 120,094 347,895 Interest & Other Net 10,009 (7,968) 10,009 (7,784) 2,139 (15,568)7,714 7,860 7,714 7,576 23,444 23,144
6 I. CHANGE IN FINANCIAL POSITION IN THE THREENINE MONTHS ENDED DECEMBERMARCH 31, 2000.2001. --------------------------------------------------------------------- In the threenine months period ended DecemberMarch 31, 2000,2001, a reduction of the working capital deficit of $7,893 resulted from a net lossprofit from operations of $263 resulted$7,466 and non fund depreciation charges of $426. The production of Autoplate instruments under a fixed price contract initiated in October 1998 was completed in January 2000. The Company has restructured its operations to perform an anticipated increase in instrument maintenance, repair and technical support services for Spiral Biotech, Inc., an Advanced Instruments company. In the quarter ended March 31, 2001, there were no sales of $122 in the deficitfour-channel Radiometers, Model 100BX, from an inventory of working capital. To counter the loss of profitability, reductions in force continued with the resignation of two more employees. The staff now totals two persons. Current liabilities were reduced by Board of Directors resolution to eliminate the accrued bonus accounts representing unused annual vacation accrued in excess of the allowed limit established in the company's personnel policies. The employees affected by this change are serving as directors and approved of this adjustment. In an effort to further reduce costs, permission was obtained from the landlord, McShea Management Inc, to sublet about one-half of the company's leased space. A sublease was arranged effective January 1, 2001 through the end of the company's lease that will pay about sixty percent of the rental and utilities expense.24 units being marketed for immediate sales. II. INCOME AND EXPENSE IN THE MOST RECENT QUARTER AND SIX MONTHNINE MONTHS PERIOD AND THE SAME QUARTER AND SIXNINE MONTHS PERIOD LAST YEAR. -------------------------------------------------------------------- Revenue for the quarter ended March 31, 2001, was $10,051 lower by $114,015$32,022 compared to the same period in 1999. An operating2000. Operating loss of $10,270 resultedfor the quarter was $14,301 compared to a$4,295 profit of $17,811 in the prior year. AcrossThe result was a net loss of $7,824 in the board reductionsmost recent quarter compared to a net loss of $2,696 in costs have beenthe same quarter in 2000. In the earlier period, the deliveries of instruments under a large-production contract was ended, while in the recent quarter a transition was being implemented to stemreduce operating cost to the losses resultinglowest practicable level commensurate with seeking revenue from drastically reduced revenue.sales of radiometers and laser scanners, including services related to those instruments. For the sixnine months period ended DecemberMarch 31, 2000,2001, revenue of $108,893$118,944 was lower by $254,979$287,001 compared to the same period in 1999.2000. The cost of sales in the recent period was reduced by about $214,000 to achieve an operating profit for the period of $13,151$120,094 compared to $53,755$347,895 in the prior year. An inventory2000. The result was operating income of 25 radiometers was completed$58,050 and net profit of $35,491 in the period withended March 31, 2000 compared to $1,150 operating loss and $7,466 net profit in 2001. These changes reflect the saleimpact of one unit prior to December 31. Requests for quotations are being received in growing numbers as is customary as the spring season approachesmajor changes in the Northern Hemisphere.business strategy of a principal customer whose business had accounted for up to 80 percent of total revenue in recent years. Management is anticipatingpursuing improved sales of thesethe company's inventory of instruments in response to increased advertising on the web site and in printed catalogs.related calibration and maintenance services. 7 PART II. OTHER FINANCIAL INFORMATION ITEM 5. As in the past, a shortage of working capital continues to be a significant problem, limiting efforts to develop new business to the fullest extent possible, as well as causing occasional delays of 30 days in payments to suppliers of materials and services. In the most recent nine months period, no accounts payable were more than 30 days old. Management also is continuing to pursue opportunities to affiliate with other companies to increase marketing and sales of its products and develop new products from Exotech's proprietary technology. In the opinion of Management, the Company should be in a position to sustain operations at least until such time as the results of current contracts and negotiations for new business is determinable. Ultimate realization of the carrying value of prepaid expenses and advances, property and equipment, and miscellaneous other assets shown in the accompanying balance sheet depend on the effect of the matters discussed herein. The dollar amount of the backlog as of DecemberMarch 31, 20002001 was $19,600,$3,100, lower by $15,396$34,900 compared to that of the prior year, and $6,268$16,575 lower than the backlog at September 30,December 31, 2000. ITEM 6 (B) There were no reports filed on Form 8-K for the sixnine months ended DecemberMarch 31, 2000.2001. 8 SIGNATURESSIGNATURE Pursuant to the requirements of the Securities Act of 1934, the Company has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized. EXOTECH INCORPORATED REGISTRANT DATE: FebruaryMAY 12, 2001 ----------------------------------------------------------------- /s/ - --------------------------------------------------------------------------- ROBERT G. LYLE, PRESIDENT AND CHIEF EXECUTIVE OFFICER 9